| Asthma and obesity: does weight loss improve asthma control? a systematic review CTB Juel, Z Ali, L Nilas, CS Ulrik Journal of Asthma and Allergy, 21-26, 2012 | 142 | 2012 |
| Obesity and asthma: impact on severity, asthma control, and response to therapy CTB Juel, CS Ulrik Respiratory care 58 (5), 867-873, 2013 | 102 | 2013 |
| Glycemic control and variability of diabetes secondary to total pancreatectomy assessed by continuous glucose monitoring CTB Juel, TF Dejgaard, CP Hansen, JH Storkholm, T Vilsbøll, A Lund, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), 168-173, 2021 | 14 | 2021 |
| The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double … CTB Juel, A Lund, MM Andersen, CP Hansen, JH Storkholm, JF Rehfeld, ... Diabetologia 63, 1285-1298, 2020 | 12 | 2020 |
| 62-OR: Evidence of Gut-Derived Glucagon in Man M Baekdal, AB Lund, NJ WEWER ALBRECHTSEN, JI Egholk, T Jorsal, ... Diabetes 68 (Supplement_1), 2019 | 2 | 2019 |
| The GLP-1 receptor agonist lixisenatide reduces postprandial glucose excursions in totally pancreatectomized patients CTB Juel, A Lund, CP Hansen, JH Storkholm, NJW Albrechtsen, JJ Holst, ... Diabetes 66, A20-A20, 2017 | 2 | 2017 |
| Intravenous arginine has no effect on the secretion of gut-derived glucagon in totally pancreatectomized subjects CTB Juel, A Lund, CP Hansen, JH Storkholm, NJW Albrechtsen, JJ Holst, ... Diabetes 66, LB81-LB81, 2017 | 2 | 2017 |
| The glucagon-like peptide-1 receptor agonist lixisenatide reduces postprandial glucose excursions in totally pancreatectomised patients CTB Juel, A Lund, CP Hansen, JH Storkholm, NJW Albrechtsen, JJ Holst, ... | 1 | 2017 |
| Gluco-metabolic response to exogenous oxytocin in totally pancreatectomized patients and healthy individuals V Kliim-Hansen, IM Gether, CTB Juel, AM Ellegaard, MG Pedersen, ... Peptides 179, 171242, 2024 | | 2024 |
| 1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans MFG GRØNDAHL, CT JUEL, A LUND, S HAEDERSDAL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Response to Letter to the Editor from McKee and McGill:“Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring” CTB Juel, TF Dejgaard, CP Hansen, JH Storkholm, T Vilsbøll, A Lund, ... The Journal of Clinical Endocrinology & Metabolism 106 (10), e4307-e4308, 2021 | | 2021 |
| Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring (vol 106, pg 168, 2021) CTB Juel, TF Dejgaard, CP Hansen, JH Storkholm, T Vilsboll, A Lund, ... JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 106 (7), E2854-E2854, 2021 | | 2021 |
| Gluco-metabolic studies in totally pancreatectomised patients C Juel | | 2020 |
| 63-OR: The Physiological Effects of Extrapancreatic Glucagon in Totally Pancreatectomized Patients Evaluated Using Glucagon Receptor Antagonism CTB Juel, AB Lund, JF Rehfeld, NJ WEWER ALBRECHTSEN, JJ Holst, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
